A Randomized, Parallel Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with DFD-01 (betamethasone dipropionate) Spray, 0.05% in Adolescent Subjects with Moderate to Severe Plaque Psoriasis
Principal Investigator (?)
To evaluate the potential of DFD-01 (betamethasone dipropionate) Spray, 0.05% to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Promius Pharma, LLC
Available at the following location(s)